The 10th edition of the AMR World Congress, set to take place on September 5th-6th at the Pennsylvania Convention Center in Philadelphia, promises again to be an enlightening gathering for innovators and stakeholders in the antimicrobial resistance (AMR) field.

“Navigating the Landscape: Strategies for Early-Stage Developmental Funding” will be one of the exciting panels of this year’s edition.  Moderated by Peter Seiler, member of the INCATE Management Team, this session will bring together people who have successfully navigated the often challenging and sometimes discouraging landscape of early-stage funding for AMR solutions.

Session Overview
Peter Seiler, who brings a deep understanding of the unique challenges facing early-stage ventures in the AMR space, will guide the discussion featuring:

Clive Mason – Programme Director AMR at LifeArc and PACE
Axel Moreland – CEO of Xiretsa, an INCATE Stage II venture
Doug Witt – CEO of Unison Medicines, an INCATE Stage I venture
Mark Engel – Chairman at Precision Biotix, who recently acquired CC Bio, an INCATE Stage I venture

Why Attend?
For entrepreneurs, researchers, and initiatives in the AMR field, securing early-stage funding is often the most significant challenge. This panel discussion will provide actionable strategies, real-world examples, and insights on how to successfully navigate this critical phase. In just a few words: this session is essential for anyone looking to turn innovative ideas into viable, funded projects.

Save the Date
Mark your calendars for September 5th at 12 pm EST at the Innovation Showcase. This is a must-attend session for gaining the insights you need to move your AMR solutions from the lab to the market!